Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 1;33(2):195-202.
doi: 10.1097/MOP.0000000000000999.

Genetic testing for unexplained perinatal disorders

Affiliations
Review

Genetic testing for unexplained perinatal disorders

Thomas Hays et al. Curr Opin Pediatr. .

Abstract

Purpose of review: Perinatal disorders include stillbirth, congenital structural anomalies, and critical illnesses in neonates. The cause of these is often unknown despite a thorough clinical workup. Genetic diseases cause a significant portion of perinatal disorders. The purpose of this review is to describe recent advances in genetic testing of perinatal disorders of unknown cause and to provide a potential diagnostic strategy.

Recent findings: Exome and genome sequencing (ES and GS) have demonstrated that significant portions of perinatal disorders are caused by genetic disease. However, estimates of the exact proportion have varied widely across fetal and neonatal cohorts and most of the genetic diagnoses found in recent studies have been unique to individual cases. Having a specific genetic diagnosis provides significant clinical utility, including improved prognostication of the outcome, tailored therapy, directed testing for associated syndromic manifestations, referral to appropriate subspecialists, family planning, and redirection of care.

Summary: Perinatal disorders of unknown cause, with nonspecific presentations, are often caused by genetic diseases best diagnosed by ES or GS. Prompt diagnosis facilitates improved clinical care. Improvements in noninvasive sampling, variant interpretation, and population-level research will further enhance the clinical utility of genetic testing.

Video abstract: http://links.lww.com/MOP/A61.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: none

Figures

Figure 1.
Figure 1.
Spectrum of genetic diagnoses from genetic investigations of perinatal disorders. Individual cases were abstracted from recent studies of fetal and neonatal disorders. These cases were assigned to broad categories of perinatal disorders, represented by the inner disc. The specific genetic diagnoses from each case are represented in the outer ring, with the number of cases shown in parentheses.

References

    1. Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012; 4(154)154ra135. - PMC - PubMed
    1. Iglesias A, Anyane-Yeboa K, Wynn J, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med 2014; 16:922–931. - PubMed
    1. Ceyhan-Birsoy O, Murry JB, Machini K, et al. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am J Hum Genet 2019; 104:76–93. - PMC - PubMed
    1. Mestek-Boukhibar L, Clement E, Jones WD, et al. Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children. J Med Genet 2018; 55:721–728. - PMC - PubMed
    1. Powis Z, Farwell Hagman KD, Spear e V, et al. Exome sequencing in neonates: diagnostic rates, characteristics, and time to diagnosis. Genet Med 2018; 20:1468–1471. - PubMed

Publication types